MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
Exact Sciences Corporation DIO Ratio 2011-2026 | EXAS
Annual DIO Ratio Exact Sciences Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 240 | 232 | 61.6 | 78.5 | 79.3 | 104 | 121 | 120 | 55.2 | 99.5 | 339 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 339 | 55.2 | 139 |
Quarterly DIO Ratio Exact Sciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.5 | 63.9 | 75 | - | 55.5 | 55.4 | 61.1 | - | 71.4 | 74.1 | 70.5 | - | 35.4 | 35.6 | 73.8 | 76.7 | 72.9 | 71.6 | 75.2 | 84.4 | 88.6 | 108 | 86.1 | 80 | 108 | 110 | 107 | 94.4 | 120 | 135 | 132 | 101 | 115 | 132 | 88.3 | 45 | 51.2 | 61.8 | 68 | 79.5 | 80.9 | 120 | 116 | 108 | 397 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 397 | 35.4 | 91.5 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M |  USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 38.55 | -1.56 % | $ 1.07 B | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 33.99 | 1.34 % | $ 366 M |  China |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 26.04 | -0.78 % | $ 787 M | USA |
 |
BioNano Genomics
BNGO
|
245 | $ 1.43 | -3.06 % | $ 1.82 M | USA |
 |
Guardant Health
GH
|
78.4 | $ 111.67 | 1.08 % | $ 13.7 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
304 | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
92.9 | $ 219.24 | -0.1 % | $ 160 B | USA |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
44.2 | $ 65.81 | -1.3 % | $ 4.55 B | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
DexCom
DXCM
|
119 | $ 73.07 | -1.26 % | $ 28.2 B | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 20.32 | -2.31 % | $ 1.09 B | USA |
 |
NeoGenomics
NEO
|
25.1 | $ 11.84 | -4.52 % | $ 1.5 B | USA |
 |
DarioHealth Corp.
DRIO
|
165 | $ 11.0 | 6.8 % | $ 312 M |  Israel |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Personalis
PSNL
|
12.1 | $ 9.31 | -6.62 % | $ 552 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
137 | $ 145.86 | -2.56 % | $ 23.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B |  Niderland |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 210.32 | -0.64 % | $ 10.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
86.5 | $ 581.3 | -1.83 % | $ 222 B | USA |
 |
Trinity Biotech plc
TRIB
|
212 | $ 0.84 | -5.23 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
51.5 | $ 39.99 | -3.82 % | $ 2.39 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 184.75 | 1.32 % | $ 20.5 B | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
21.7 | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 269.85 | 0.01 % | $ 22.6 B | USA |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 386.62 | -0.44 % | $ 29.4 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 178.39 | -4.03 % | $ 14.7 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
91.6 | $ 673.89 | -0.42 % | $ 55.6 B | USA |